Biologics targeting type I interferons in SLE: A meta-analysis and systematic review of randomised controlled trials.
Jeffery Wei Heng KohCheng Han NgSen Hee TayPublished in: Lupus (2020)
This meta-analysis substantiates IFNAR as a therapeutic target in SLE. Inhibition of type I IFNs predisposes to herpes zoster and other viral infections.